Second Sight Medical Products Inc EYES will acquire privately-held Nano Precision Medical Inc in an all-stock transaction.
- Second Sight Medical develops implantable visual prosthetics.
- Under the agreement, Nano Precision Medical will merge with a wholly-owned subsidiary of Second Sight.
- The surviving company Nano Precision Medical will be owned by Second Sight. The newly-formed merged company will focus on developing innovative implants for chronic diseases.
- The combined company will be under NPM's co-founder, CEO, and Chairman, Adam Mendelsohn.
- Second Sight will issue approximately 134 million shares and acquire about 23% equity of the combined company.
- The transaction is expected to close in Q2 / Q3 of FY22.
- Nano Precision Medical's lead program, NPM-119, is a near clinical stage GLP-1 receptor agonist developed to treat patients with Type 2 diabetes for up to 6 months with a single, tiny subdermal implant.
- The first human trial for NPM-119 is anticipated by late 2022.
- Before the merger, Second Sight will provide $8 million to NPM for working capital and speed up pipeline programs. EYES shareholders will join NPM shareholders, including AstraZeneca plc AZN.
- AstraZeneca has been a strategic investor in NPM since 2016.
- Price Action: EYES shares are trading 8.57% higher at $1.52 during the premarket session on the last check Tuesday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.